Pediatric Hematology / Oncology

Barbara Chimbunde, PA-C

Jose Esquilin, M.D.

Jeff Hanrahan, M.D.

Britni Lehde, P.N.P.

Nkechi Mba, M.D.

 

<< Go Back to Specialties List

Pediatric Hematology / Oncology

Jose Esquilin, M.D., Hematology/Oncology

Jose Esquilin, M.D., Pediatric Hematology and OncologyDr. Jose Manuel Esquilin is an Attending Hematologist/Oncologist at the Cancer and Blood Disorders Center.  He graduated from Drew University with a degree in Neuroscience.  He went on to attend medical school at the Columbia University College of Physicians and Surgeons in New York City.  He completed residency training at Yale-New Haven Children’s Hospital before returning to New York to enter fellowship training in Hematology, Oncology, and Stem Cell Transplantation at the Morgan Stanley Children’s Hospital of New York Presbyterian Hospital.  During fellowship he conducted research on the molecular regulation of Acute Myeloid Leukemia.  In 2011, he and his family relocated to Corpus Christi to join the faculty at Driscoll Children’s Hospital.  He is board-certified in Pediatrics and board-eligible in Pediatric Hematology/Oncology. 

PUBLICATIONS AND PRESENTATIONS:

Esquilin, JM, Takemoto, CM, Green, NS. Female Factor IX deficienty due to maternally inherited X-inactivation.  Clinical Genetics, 2012.  Vol. 82(6); 583-6.

Liao, Y., Radhakrishnan, K., Esquilin, JM, Mehta, B., van de Ven, C., and Cairo, M.S. Clinical Application of Umbilical Cord Blood-Derived Stem Cells for Tissue Regeneration. Hayat, M.A., ed. Springer Publishing, New York, 2012

Harel, S, Tu, EY, Weisberg, S, Esquilin, JM, Chambers, SM, Liu B, Carson, CT, Studer, L, Reizis, B, Tomishima, MJ.  Zfx controls the self-renewal of human embryonic stem cells.  PloS One, 2012. Vol. 7(8); e42302.

Top, KA, Esquilin, JM, Yen, C, Esona, MD, Gentsch, JR, Bhatia, M, Larussa, P.  Detection of mutations in antigenic regions of rotavirus viral proteins 4 and 7 in a child with chronic shedding of rotavirus vaccine-type strain.  Pediatric Infectious Disease Journal, 2011. Vol. 30(7);630.

S.S. Hong, G.T. Gibney, J.M. Esquilin, JM, Yu, Y. Xia, Effect of protein kinases on
lactate dehydrogenase activity in cortical neurons during hypoxia, Brain
Research, 1009 (2004) 195-202.

Jose M. Esquilin, MD, Zhezhen Jin, PhD, Carmella van de Ven, MA, Bradford
Tallamy, BA, Tracey Schonfeld, RN, Virginia Moore, RN, Lauren Harrison, RN,
Erin Morris, RN, Monica Bhatia, MD, Diane George, MD, James Garvin, MD,
Brigid Bradley, MD, Joseph Schwartz, MD, Lee Ann Baxter-Lowe, PhD, Prakash
Satwani, MD, and Mitchell S. Cairo, MD. Risk Factors Associated with Day 100
Treatment Related Mortality (TRM), Grade II-IV AGVHD and Overall Survival
(OS) in Cord Blood Transplant (CBT) in Pediatric Recipients: Reduced Intensity
Conditioning (RIC) is Associated with a Significant Decrease in Day 100 TRM
and AGVHD Resulting in an Increase in 3 Year Overall Survival (2009). Oral
Presentation, 22nd Annual Meeting of the American Society of Pediatric
Hematology/Oncology, San Diego, CA April 22nd.

Jeffrey J. Swensen, Archana M. Agarwal, Jose M. Esquilin, Sabina Swierczek, Ajay Perumbeti, Dottie Hussey, Margaret Lee, Clinton H. Joiner, Genevieve Pont-Kingdon, Elaine Lyon, and Josef T. Prchal. Sickle cell disease resulting from uniparental disomy in a child who inherited sickle cell trait. Blood, 2010.
Vol. 116, No. 15, pp. 2822-2825.


Pediatric Hematology-Oncology
Children's Physician Services of South Texas
 
3533 S. Alameda Street
Corpus Christi, TX 78411 
Phone: (361) 694-5311
Fax: (361) 808-2069
Hours: M - F 8:30 a.m. - 4:30 p.m.